A pharmacological approach to enhancing the therapeutic index of corticosteroids in airway inflammatory disease

Current Opinion in Pharmacology

Volumn 5, Issue 3 SPEC. ISS., 2005, Pages 221-226

  Uings, Iain J ^a   Farrow, Stuart N ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2,3 DIHYDROBENZOFURAN 7 YL) 2 HYDROXY 3,3 DIMETHYL N (4 METHYL 1 OXO 2,3 BENZOXAZIN 6 YL) 2 TRIFLUOROMETHYLBUTANAMIDE; AL 438; BECLOMETASONE; BECLOMETHASONE PROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETAMETHASONE; BUDESONIDE; CICLESONIDE; CORTICOSTEROID; CORTICOSTEROID DERIVATIVE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; FLUTICASONE PROPIONATE; GLUCOCORTICOID RECEPTOR; GLUCOSE; HYDROCORTISONE; INITIATION FACTOR 2; NUCLEAR RECEPTOR COACTIVATOR 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROOPIOMELANOCORTIN; RU 24858; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BODY WEIGHT DISORDER; BONE DENSITY; BONE DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID RELEASE; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG EFFICACY; DRUG INACTIVATION; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG STRUCTURE; EYE DISEASE; FEEDBACK SYSTEM; GROWTH RETARDATION; HUMAN; HYPERGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOLECULAR MECHANICS; MOUSE; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; RESPIRATORY TRACT INFLAMMATION; SKIN DISEASE; THYMUS DISEASE; WEIGHT REDUCTION;

EID: 18744408211     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2004.12.003     Document Type: Review

References (30)

1. P.J. Barnes Anti-inflammatory actions of glucocorticoids: Molecular mechanisms Clin Sci 94 1998 557-572
2. D.M. Williams Clinical considerations the use of inhaled corticosteroids for asthma Pharmacotherapy 21 2001 38S-48S
3. D.B. Allen L. Bielory H. Derendorf R. Dluhy G.L. Colice S.J. Szefler Inhaled corticosteroids: Past lessons and future issues J Allergy Clin Immunol 112 2003 S1-S40
4. I.E. Lundberg C. Grundtman E. Larsson L. Klareskog Corticosteroids - from an idea to clinical use Best Pract Res Clin Rheumatol 18 2004 7-19
5. M. Johnson Development of fluticasone propionate and comparison with other inhaled corticosteroids J Allergy Clin Immunol 101 1998 S434-S439
6. M. Humbert Ciclesonide: A novel inhaled corticosteroid Expert Opin Investig Drugs 13 2004 1349-1360
7. S. Edsbacker R. Brattsand Budesonide fatty acid esterification: A novel mechanism prolonging binding to airway tissue. Review of available data Ann Allergy Asthma Immunol 88 2002 609-616
8. H.S. Nelson Advair: Combination treatment with fluticasone propionate/ salmeterol in the treatment of asthma J Allergy Clin Immunol 107 2001 397-416
9. S.M. Hollenberg C. Weinberger E.S. Ong G. Cerelli A. Oro R. Lebo E.B. Thompson M.G. Rosenfeld R.M. Evans Primary structure and expression of a functional human glucocorticoid receptor cDNA Nature 318 1985 635-641
10. Ray A, Siegel MD, Prefontaine KE, Ray P: Anti-inflammation: Direct physical association and functional antagonism between transcription factor NF-KB and the glucocorticoid receptor. Chest 107:139S.
11. R.I. Scheinman A. Gualberto C.M. Jewell J.A. Cidlowski AS. Baldwin Jr. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors Mol Cell Biol 15 1995 943-953
12. Y.X. Tao C. Williams-Skipp R.I. Scheinman Mapping of glucocorticoid receptor DNA binding domain surfaces contributing to transrepression of NF-kappa B and induction of apoptosis J Biol Chem 276 2001 2329-2332
13. M.G. Belvisi S.L. Wicks C.H. Battram S.E.W. Bottoms J.E. Redford Woodman PBT S.E. Webber M.L. Foster Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity J Immunol 166 2001 1975-1982
14. T.M. Wintermantel S. Berger E.F. Greiner G. Schutz Genetic dissection of corticosteroid receptor function in mice Horm Metab Res 36 2004 387-391
15. H.M. Reichardt K.H. Kaestner J. Tuckermann O. Kretz O. Wessely R. Bock P. Gass W. Schmid P. Herrlich P. Angel G. Schutz DNA binding of the glucocorticoid receptor is not essential for survival Cell 93 1998 531-541
16. H.M. Reichardt J.P. Tuckermann A. Bauer G. Schutz Molecular genetic dissection of glucocorticoid receptor function in vivo Z Rheumatol 59 Suppl 2 2000 1-5
17. B.M. Vayssiere S. Dupont A. Choquart F. Petit T. Garcia C. Marchandeau H. Gronemeyer M. Resche-Rigon Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo Mol Endocrinol 11 1997 1245-1255
18. M.G. Belvisi T.J. Brown S. Wicks M.L. Foster New glucocorticosteroids with an improved therapeutic ratio? Pulm Pharmacol Ther 14 2001 221-227
19. K. Tanigawa H. Nagase K. Ohmori K. Tanaka H. Miyake M. Kiniwa K. Ikizawa Species-specific differences in the glucocorticoid receptor transactivation function upon binding with betamethasone-esters Int Immunopharmacol 2 2002 941-950
20. J.N. Miner Designer glucocorticoids Biochem Pharmacol 64 2002 355-361
21. M.J. Coghlan P.B. Jacobson B. Lane M. Nakane C.W. Lin S.W. Elmore P.R. Kym J.R. Luly G.W. Carter R. Turner et al. A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects Mol Endocrinol 17 2003 860-869
22. H. Schacke A. Schottelius W.D. Docke P. Strehlke S. Jaroch N. Schmees H. Rehwinkel H. Hennekes K. Asadullah Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects Proc Natl Acad Sci USA 101 2004 227-232
23. A. Biola K. Andreau M. David M. Sturm M. Haake J. Bertoglio M. Pallardy The glucocorticoid receptor and STAT6 physically and functionally interact in T-lymphocytes FEBS Lett 487 2000 229-233
24. J. Mullick H.K. Anandatheerthavarada G. Amuthan S.V. Bhagwat G. Biswas V. Camasamudram N.K. Bhat S.E.P. Reddy V. Rao N.G. Avadhani Physical interaction and functional synergy between glucocorticoid receptor and Ets2 proteins for transcription activation of the rat cytochrome P-450c27 promoter J Biol Chem 276 2001 18007-18017
25. N.J. McKenna B.W. O'Malley From ligand to response: Generating diversity in nuclear receptor coregulator function J Steroid Biochem Mol Biol 74 2000 351-356
26. N.J. McKenna B.W. O'Malley Nuclear receptor coactivators - an update Endocrinology 143 2002 2461-2465
27. N.J. McKenna B.W. O'Malley Combinatorial control of gene expression by nuclear receptors and coregulators Cell 108 2002 465-474
28. I. Rogatsky J.C. Wang M.K. Derynck D.F. Nonaka D.B. Khodabakhsh C.M. Haqq B.D. Darimont M.J. Garabedian K.R. Yamamoto Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor Proc Natl Acad Sci USA 100 2003 13845-13850
29. J.C. Wang M.K. Derynck D.F. Nonaka D.B. Khodabakhsh C.M. Haqq K.R. Yamamoto Chromatin immunoprecipiation scanning identifies primary glucocorticoid receptor target genes Proc Natl Acad Sci USA 101 2004 15603-15608
30. R.K. Bledsoe V.G. Montana T.B. Stanley C.J. Delves C.J. Apolito D.D. McKee T.G. Consler D.J. Parks E.L. Stewart T.M. Willson et al. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition Cell 110 2002 93-105